Plain-English translation of NCT05919342 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether screening people at high risk for heart failure—using a blood test to measure a natural heart protein and follow-up heart imaging—can catch the disease earlier than standard care. The study will compare two groups: one that receives routine care, and one that gets the screening tests. Researchers hope this approach will help identify heart failure before symptoms become serious.
Many people have heart failure but don't know it because they haven't been tested. By the time symptoms appear, the condition may have already damaged the heart. This trial is trying to find out if catching heart failure early through screening can improve outcomes and help doctors treat the disease before it gets worse.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly placed into one of two groups. In the routine care group, you'll receive standard medical care and be monitored through electronic health records. In the screening group, you'll have a blood test to measure a heart protein, and if the result is high, you'll receive a handheld ultrasound of your heart, a heart rhythm test (ECG), and an examination by a healthcare provider. If heart failure is found, you'll be referred for appropriate treatment. The study involves participants from five countries and will track your health over time.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States
Canada
Denmark
Sweden